Creative Planning’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Creative Planning’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-56,932	Closed	-$39K	–	2794
2020 Q4	$39K	Buy	56,932 +4,373	+8%	+$9.31K	﹤0.01%	2129
2020 Q3	$118K	Buy	52,559 +743	+1%	+$2.12K	﹤0.01%	1802
2020 Q2	$186K	Sell	51,816 -2,325	-4%	-$8.39K	﹤0.01%	1550
2020 Q1	$206K	Buy	54,141 +253	+0.5%	+$833	﹤0.01%	1379
2019 Q4	$162K	Buy	+53,888	New	+$140K	﹤0.01%	1682

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Creative Planning's BMY.RT Position: Q1 2021 in Review

Creative Planning sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 56,932 shares — an estimated $39K sold.

Creative Planning first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $206K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Creative Planning reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Creative Planning sold 56,932 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $39K.
Creative Planning first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Creative Planning's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $206K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Creative Planning's 13F filing for Q1 2021, filed 30 Apr 2021.